Abstract 2845
Background
Adolescents and young adults (AYA) with cancer represent a unique demographic with distinctive developmental and psychosocial pressures. We sought to understand the baseline psychosocial needs of AYAs compared to case matched older adults at diagnosis using the Canadian Problem Checklist (CPC) and the Psychosocial Screen for Cancer - Revised (PSSCAN-R). The CPC is a tool to identify patient concerns in six domains: emotional, practical, spiritual, social, informational and physical. The PSSCAN-R is a validated tool to assess psychosocial needs and distress.
Methods
All AYA patients who completed the CPC and PSSCAN-R within 6 months of their cancer diagnosis between 2011-2016 in the province of British Columbia, Canada were included in the study. Baseline demographics were collected through retrospective chart review. A 3:1 case match based on gender, primary tumor site and metastatic status was performed with older adults (>40 years old) and AYA (18-40 years old). Statistical analysis was undertaken through Chi squared and Fisher’s exact test.
Results
2045 AYAs were case matched by common AYA tumor sites with 6050 older adults. Top five tumor sites were breast (20.4%), lymphoma (11.5%), gastrointestinal (10.8%), thyroid (10.6%), cervix/endometrium (8.0%). 61.9% were female and 12.1% had metastatic disease at diagnosis. The top 6 concerns for AYAs (% AYA, % older adults) were: fear/worry (56.6, 42.9) understanding of illness (47.6, 41.4), sleep (35.2, 28.9), sadness (34.1, 20.0), finances (33.8, 15.0), school/work (33.7, 10.5), all p < 0.01. AYAs reported higher anxiety at baseline (% AYA, % older adults): subclinical (26.0, 19.9), clinical (26.6, 17.1), p < 0.01.
Conclusions
Significant differences in baseline psychosocial needs for AYAs exist across multiple domains. Specifically, higher emotional, financial, school/work distress and baseline anxiety scores. Tailored support with early focus on these domains would benefit this unique and under-served population.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
4852 - Impact of routine screening and preemptive treatment on hepatitis B virus reactivation (HBVr) in patients receiving chemotherapy
Presenter: Celine Marty
Session: Poster Display session 1
Resources:
Abstract
5225 - The uptake, patient satisfaction and efficacy of scalp cooling among patients receiving chemotherapy in an Irish oncology day ward.
Presenter: William Maher
Session: Poster Display session 1
Resources:
Abstract
1901 - Placebo adverse events (AEs) in targeted and immune cancer therapy in the adjuvant and advanced setting: A systematic review and meta-analysis
Presenter: Diego Enrico
Session: Poster Display session 1
Resources:
Abstract
3258 - Reduced antibody levels and high seronegativity rates against vaccine preventable diseases pose a risk factor for infections in patients with solid and hematologic cancers
Presenter: Angela Guzek
Session: Poster Display session 1
Resources:
Abstract
3211 - Prognostic Factors Influencing Outcome After Therapy With Brentuximab Vedotin in Patients with Relapsed or Refractory Hodgkin's Lymphoma
Presenter: Veselina Goranova - Marinova
Session: Poster Display session 1
Resources:
Abstract
4949 - Phase I Study of CC-90010 in Patients With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin Lymphoma (R/R NHL)
Presenter: Victor Moreno
Session: Poster Display session 1
Resources:
Abstract
2271 - Pretreatment coagulation factors related to prognosis in patients with natural killer/T cell lymphoma
Presenter: Yue Chai
Session: Poster Display session 1
Resources:
Abstract
4335 - Diffuse large B cell lymphoma in the elderly. A retrospective analysis of standard versus alternative treatments
Presenter: Irene Sillero
Session: Poster Display session 1
Resources:
Abstract
5117 - MIPI as a superior prognostic tool in Mantle Cell Lymphoma compared to monocyte-lymphocyte, neutrophil-lymphocyte and platelet-lymphocyte ratios
Presenter: Filipa Macedo
Session: Poster Display session 1
Resources:
Abstract
5135 - Dose adjustment of chemotherapy in aggressive lymphoma using automated and standardized analysis and evaluation of DNA double strand breaks
Presenter: Julia Schröder
Session: Poster Display session 1
Resources:
Abstract